The long term objective of this project is to identify the genomic basis of HLA association with susceptibility to insulin dependent diabetes mellitus (IDDM) and auto-immune-type vitiligo (ATV) and determine the relationship of HLA genotype frequency differences between African Americans and Caucasians to population differences in the incidence of IDDM. The analysis of HLA variability in disease association is enhanced in African Americans because of the greater degree of HLA polymorphisms found in this population. The polymerase chain reaction technique and hybridization with sequence specific oligonucleotide probes will be used to define HLA- DR and DQ alleles in Africa-American patients with IDDM and ATV in a case-control study. Family members will also be ascertained to determine HLA haplotypes. We hypothesize structural homologies among susceptibility alleles and protective alleles and/or haplotypes.
The specific aims are to define DRB1, DRB3, DRB4, DRB5, DQA1, and QB1 alleles and haplotypes in patients and controls; determine the frequency of alleles at each of these loci in IDDM and ATV; analyze the cis-trans-dose effect of DQA1 Arg52 and DQB1 Asp57 alleles in IDDM patients and controls, and estimate the IDDM genotype specific incidence for African Americans in Washington, D.C. Allelic hypervariable region sequence homology of DR4 early age of onset and DR6 late age of onset susceptibility alleles in ATV will be analyzed and compared with DR4 susceptibility allele(s) in IDDM. Also, susceptible and protective alleles/haplotypes, with a focus on the DRB1*0302,DQB1*0402,DQA1*0401 unique polymorphism in African Americans, will be evaluated relative to association with disease heterogeneity. This project focuses on the definition of genomic polymorphisms in HLA class II genes known to be associated with susceptibility to autoimmune disease. Unique HLA polymorphisms in African Americans will be used to assess the relative effect of DQA1, DQB1, and DRB alleles in susceptibility to IDDM and ATV. The molecular characterization of HLA-DR and DQ alleles and haplotypes at the DNA level will refine the definition of disease- associated alleles and/or sequence motifs and may be of great importance in better understanding the significance of immunogenetic factors in the pathogenesis of IDDM and ATV. Moreover, new information generated on diseases susceptibility motifs may be instructive in the design of gene therapy approaches to these types of autoimmune diseases.

Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
1996
Total Cost
Indirect Cost
Popa, Laurentiu S; Hewitt, Angela L; Ebner, Timothy J (2013) Purkinje cell simple spike discharge encodes error signals consistent with a forward internal model. Cerebellum 12:331-3
Fuller, T L; Canada, R G (1999) Enhancement of cisplatin cytotoxicity by terbium in cisplatin-resistant MDA/CH human breast cancer cells. Cancer Chemother Pharmacol 44:249-52
Canada, R G; Paltoo, D N (1998) Binding of terbium and cisplatin to C13* human ovarian cancer cells using time-resolved terbium luminescence. Biochim Biophys Acta 1448:85-98
Paltoo, D N; Canada, R G (1998) Effects of terbium on the cytotoxicity of cisplatin in FaDu human head and neck squamous cell carcinoma. Cancer Biochem Biophys 16:213-27
Ting, P; Cushenberry, P A; Friedman, T C et al. (1997) Enhanced brain opioid receptor activity precedes blood-brain barrier disruption. Acta Neurochir Suppl 70:250-3
Mack, K M; Canada, R G; Andrews, P A (1997) The effects of terbium on the cellular accumulation of cisplatin in MDA-MB-231 human breast tumor cells. Cancer Chemother Pharmacol 39:217-22
Dennis, G C; Dehkordi, O; Millis, R M et al. (1996) Monitoring of median nerve somatosensory evoked potentials during cervical spinal cord decompression. J Clin Neurophysiol 13:51-9
Canada, R G; Andrews, P A; Mack, K M et al. (1995) The effects of terbium on the accumulation of cisplatin in human ovarian cancer cells. Biochim Biophys Acta 1267:25-30
Ting, P; Xu, S; Krumins, S (1994) Endogenous opioid system activity following temporary focal cerebral ischemia. Acta Neurochir Suppl (Wien) 60:253-6
Canada, R G (1993) Calcium receptor binding of cisplatin and terbium in human breast tumor cells after hyperthermia. Radiat Res 133:170-5